Tecentriq

Description

Tecentriq

Combination therapy for hepatocellular carcinoma
Combination therapy for unresectable or metastatic melanoma
Combination therapy for unresectable locally advanced or metastatic triple-negative breast cancer
Combination therapy for small cell lung cancer
Monotherapy for locally advanced or metastatic non-small cell lung cancer
Monotherapy for locally advanced or metastatic urothelial cancer

Active ingredient: atezolumab

Storage temperature 4-8 degrees

Prescription drug.